Agile Therapeutics is a women's healthcare company. The company's primary product candidate, Twirla, also known as AG200-15, is a once-weekly prescription combination hormonal contraceptive patch that is at the end of clinical development. Twirla is a combined hormonal contraceptives patch that contains the active ingredients ethinyl estradiol, which is a synthetic estrogen, and levonorgestrel, which is a type of progestin, a synthetic steroid hormone. The company also has a pipeline of other transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle, and AG200-SP, which is a regimen designed to provide shorter lighter periods.

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's primary focus is on the development of its key product candidate, Neutrolin

Good Times Restaurants operates and franchises Bad Daddy's Burger Bar restaurants (Bad Daddy's) and Good Times Burgers & Frozen Custard (Good Times) restaurants. Bad Daddy's and Good Times are two distinctly different, yet complementary, restaurant concepts. Bad Daddy's operates in the casual dining segment of the restaurant industry. Bad Daddy's operates all of its company-owned restaurants under a table service / full-bar service model. The menu is comprised of burgers, salads, sandwiches, and appetizers. Good Times is a quick service restaurant concept offering hand crafted products. Good Times provides a menu of Angus beef and chicken.

HomeTrust Bancshares is a bank holding company. Through its subsidiaries, the company's business consists of accepting deposits from the general public and investing those funds, along with borrowed funds, in loans secured by first and second mortgages on one- to four-family residences including home equity loans, construction and land/lot loans, commercial real estate loans, construction and development loans, commercial and industrial loans, U.S. Small Business Administration loans, equipment finance leases, indirect automobile, and municipal leases. The company also purchases investment securities consisting of securities issued by U.S. Government agencies and government-sponsored enterprises.

Hudson Pacific Properties is a holding company. Through its subsidiaries, the company is a self-administered and self-managed real estate investment trust focused on acquiring, repositioning, developing and operating office and studio properties in submarkets throughout Northern and Southern California and the Pacific Northwest. The company owns its interests in all of its properties and conducts substantially all of its business through its operating partnership, Hudson Pacific Properties, L.P. The company has two segments: office properties, which are located in Northern and Southern California and the Pacific Northwest; and studio properties, which are located in Southern California.

Provention Bio is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company's principal product candidates include: PRV-031 (teplizumab, anti-CD3 mAb) for the interception of type 1 diabetes; PRV-015 (anti-IL-15 mAb) for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 (oral CSF-1R inhibitor) for the treatment of Crohn's disease; PRV-300 (anti-TLR3 mAb) for the treatment of ulcerative colitis; and PRV-3279 (humanized anti-CD32B and CD79B bispecific) for the treatment of lupus.

Stein Mart is a national off-price retailer providing apparel, home decor, accessories and shoes. The company operates in stores and an E-commerce retail selling site. The company's stores are located in the Northeast, Midwest, Southeast, Texas and the Southwest. The company's typical store has a racetrack design, centralized check-out, and individual dressing rooms at discount prices. The company's stores provide services such as merchandise locator service, a Preferred Customer program, co-branded and private label credit card programs, and electronic gift cards. The company also sells merchandise offerings on its website at www.steinmart.com.

Velocity Composites is engaged in the sale of kits of composite material and related products to the aerospace industry.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.